Zeitschrift für klinische und experimentelle Neuroimmunologie

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Anweisungen für Autoren

Das Journal of Clinical & Experimental Neuroimmunology bringt regelmäßig Artikel in allen Bereichen der Neuroimmunologie. Die Zeitschrift begrüßt die Einreichung von Manuskripten, die die allgemeinen Kriterien der Signifikanz und wissenschaftlichen Exzellenz erfüllen. Die Beiträge werden ca. 15 Tage nach Annahme veröffentlicht.

Als Mitglied der Publisher International Linking Association (PILA) befolgt das Journal of Clinical & Experimental Neuroimmunology von OMICS International die Veröffentlichungsrichtlinien der Creative Commons Attribution License und Scholars Open Access.

Senden Sie das Manuskript unter https://www.scholarscentral.org/submissions/clinical-experimental-neuroimmunology.html  oder als E-Mail-Anhang an die Redaktion unter    manuscript@omicsonline.org .

Eine Manuskriptnummer wird innerhalb von 72 Stunden per E-Mail an den entsprechenden Autor gesendet.

Internationale OMICS-Richtlinie zum NIH-Mandat

OMICS International unterstützt Autoren, indem es die veröffentlichte Version von Artikeln von NIH-Stipendiaten und in Europa oder Großbritannien ansässigen biomedizinischen oder biowissenschaftlichen Stipendiaten unmittelbar nach der Veröffentlichung in PubMed Central veröffentlicht

Redaktionelle Richtlinien und Verfahren

Das Journal of Clinical & Experimental Neuroimmunology verfolgt eine fortschrittliche Redaktionspolitik, die Forscher dazu ermutigt, die Originalforschung, Rezensionen und redaktionellen Beobachtungen als Artikel einzureichen, gut unterstützt durch Tabellen und grafische Darstellungen.

Hinweis: Für jegliches wissenschaftliches Fehlverhalten, einschließlich Plagiate in ihren Artikeln, tragen allein die Autoren die Verantwortung; Der Herausgeber übernimmt keine Verantwortung für wissenschaftliches Fehlverhalten in veröffentlichten Artikeln. Als Herausgeber befolgen wir streng wissenschaftliche Richtlinien und den Rat des EIC, jeden Artikel jederzeit zurückzuziehen oder zu ändern, wenn in einem Artikel wissenschaftliches Fehlverhalten oder Fehler aufgetreten sind.

Artikelbearbeitungsgebühren (APC):

OMICS International Journal of Clinical & Experimental Neuroimmunology is self-financed and does not receive funding from any institution/government. Hence, the Journal operates solely through processing charges we receive from the authors and some academic/corporate sponsors. The handling fee is required to meet its maintenance. Being an Open Access Journal, Journal of Clinical & Experimental Neuroimmunology does not collect subscription charges from readers that enjoy free online access to the articles. Authors are hence required to pay a fair handling fee for processing their articles. However, there are no submission charges. Authors are required to make payment only after their manuscript has been accepted for publication.

Manuscript Type Article Processing Charges
USD EURO GBP
Regular Articles 950 1050 900

Average Article prorcessing time (APT) is 45 days

The basic article processing fee or manuscript handling cost is as per the price mentioned above on the other hand it may vary based on the extensive editing, colored effects, complex equations, extra elongation of no. of pages of the article, etc.

Submission of an Article: In order to reduce delays, authors should adhere to the level, length and format of the OMICS International Journals at every stage of processing right from manuscript submission to each revision stage. Submitted articles should have a 300 words summary/abstract, separate from the main text. The summary should provide a brief account of the work by clearly stating the purpose of the study and the methodology adopted, highlighting major findings briefly. The text may contain a few short subheadings of no more than 40 characters each.

Author Withdrawal Policy: From time to time, an author may wish to withdraw a manuscript after submitting it. Changing ones mind is an authors prerogative. And an author is free to withdraw an article at no charge as long as it is withdrawn within 5 days of its initial submission.

If you have concerns or questions about it, please contact us for further discussion. We welcome your input.

Language Translation Services: With an intention to take scientific & health care information globally, OMICS International has introduced language translation services. This service enables the author to reach the global audience in many major world languages at a time as our language experts in Spanish, French and German can translate the article from English into different world languages as per the author’s requirement. This service grants a global presence to the author and his/her scholarship.As OMICS is an open access publisher, we do not seek or get financial assistance from any organization. Authors who wish to avail our translation services and who are interested to publish their paper in other languages, are requested to pay the following additional charges along with the article processing charges.

Formats for OMICS International Contributions: OMICS International accepts various formats of literary works such as research articles, reviews, abstracts, addendums, announcements, article-commentaries, book reviews, rapid communications, letters to the editor, annual meeting abstracts, conference proceedings, calendars, case-reports, corrections, discussions, meeting-reports, news, obituaries, orations, product reviews, hypotheses and analyses.

Article Preparation Guidelines

  • Authors are expected to attach an electronic covering letter completely mentioning the type of manuscript (e.g, Research article, Review articles, Brief Reports, Case study etc.) Unless invited on a special case, authors cannot classify a particular manuscript as Editorials or Letters to the editor or concise communications.
  • Confirm that each individual named as an author meets the uniform requirements of the Journal of Clinical & Experimental Neuroimmunologys criteria for authorship.
  • Please make sure that the article submitted for review/publication is not under consideration elsewhere simultaneously.
  • Clearly mention financial support or benefits if any from commercial sources for the work reported in the manuscript, or any other financial interests that any of the authors may have, which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work.
  • A clear title of the article along with complete details of the author/s (professional/institutional affiliation, educational qualifications and contact information) must be provided in the tile page.
  • Corresponding author should include address, telephone number, fax number, and e-mail address in the first page of the manuscript and authors must address any conflict of interest with others once the article is published.
  • Number all sheets in succession, including references, tables, and figure legends.
  • Title page is page 1. On the first page, type the running head (short title for top of each page), title (which cannot include any acronyms), names of the authors and their academic degrees, grants or other financial supporters of the study, address for correspondence and reprint requests, and corresponding author's telephone and fax numbers and e-mail address.

Guidelines for Research Articles

  • Research articles are articles written based on the empirical/secondary data collected using a clearly defined research methodology, where conclusion/s is drawn from the analysis of the data collected.
  • The information must be based on original research that adds to the body of knowledge in Neuroimmunology.
  • Article/s should provide a critical description or analysis of the data presented while adding new and rapidly evolving areas in the field.
  • Include an abstract of at least 300 words with 7 to 10 important keywords.
  • The abstract should be divided into Objective, Methods, Results, and Conclusion.
  • Research articles must adhere to a format constituting the introduction followed by a brief review of relevant literature, methodology applied (to collect the data), discussion and References, Tables, and Figure Legends.

Review Articles

  • Review articles are written based mostly on secondary data that is falling in line with the theme of the journal. They are brief, yet critical discussions on a specific aspect of the subject concerned. Reviews generally start with the statement of the problem with a brief abstract of 300 words and few key words. Introduction generally brings the issue forward to the readers followed by analytical discussion with the help of necessary tables, graphs, pictures and illustrations wherever necessary. It summarizes the topic with a conclusion. All the statements or observations in the review articles must be based on necessary citations, providing complete reference at the end of the article.

Commentaries

  • Commentaries are opinion articles written mostly by the veteran and experienced writers on a specific development, recent innovation or research findings that fall in line with the theme of the journal. They are very brief articles with the title and abstract that provides the gist of the topic to be discussed, with few key words. It straight away states the problems and provides a thorough analysis with the help of the illustrations, graphs and tables if necessary. It summarizes the topic with a brief conclusion, citing the references at the end.

Case Study

  • Case studies are accepted with a view to add additional information related to the investigative research that advances in the field of Neuroimmunology.
  • It should add value to the main content/article submitted, by providing key insights about the core area. Cases reports must be brief and follow a clear format such as Cases and Methods Section (That describe the nature of the clinical issue and the methodology adopt to address it), discussion section that analyzes the case and a Conclusion section that sums up the entire case.

Editorials

  • Editorials are concise commentaries on a currently published article/issue on Neuroimmunology. Editorial office may approach for any such works and authors must submit it within three weeks from the date of receiving invitation.

Clinical Images

  • Clinical Images are nothing but photographic depictions of Neuroimmunology and it should not exceed more than 5 figures with a description, not exceeding 300 words. Generally no references and citations are required here. If necessary, only three references can be allowed.
  • Do not add separate figure legends to clinical images; the entire clinical image text is the figure legend. Images should be submitted with the manuscript in one of the following formats: .tiff (preferred) or .eps.

Letters to the Editor/Concise Communications

  • Letters to the editor should be limited to commentaries on previous articles published with specific reference to issues and causes related to it.  It should be concise, comprehensive and brief reports of cases or research findings. It does not follow a format such as abstract, subheads, or acknowledgments. It is more a response or the opinion of the reader on a particular article published and should reach the editor within 6 months of article publication.

Acknowledgement: This section includes acknowledgment of people, grant details, funds, etc.

Note: If an author fails to submit his/her work as per the above instructions, they are requested to maintain clear titles namely headings, subheading.

References: Only published or accepted manuscripts should be included in the reference list. Meetings abstracts, conference talks, or papers that have been submitted but not yet accepted should not be cited. All personal communications should be supported by a letter from the relevant authors.OMICS uses the numbered citation (citation-sequence) method. References are listed and numbered in the order that they appear in the text. In the text, citations should be indicated by the reference number in brackets. Multiple citations within a single set of brackets should be separated by commas. When there are three or more sequential citations, they should be given as a range. Example: "... now enable biologists to simultaneously monitor the expression of thousands of genes in a single experiment [1,5-7,28]". Make sure the parts of the manuscript are in the correct order for the relevant journal before ordering the citations. Figure captions and tables should be at the end of the manuscript.Authors are requested to provide at least one online link for each reference as following (preferably PubMed).Because all references will be linked electronically as much as possible to the papers they cite, proper formatting of the references is crucial. Please use the following style for the reference list:

Examples Published Papers

  1. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
  2. Brusic V, Rudy G, Honeyman G, Hammer J, Harrison L (1998) Prediction of MHC class II- binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics 14: 121-130.
  3. Doroshenko V, Airich L, Vitushkina M, Kolokolova A, Livshits V, et al. (2007) YddG from Escherichia coli promotes export of aromatic amino acids. FEMS Microbiol Lett 275: 312-318.

Note: Please list the first five authors and then add "et al." if there are additional authors.

Electronic Journal Articles Entrez Programming Utilities

  1. https://eutils.ncbi.nlm.nih.gov/entrez/query/static/eutils_help.html

Books

  1. Baggot JD (1999) Principles of drug disposition in domestic animals: The basis of Veterinary Clinical Pharmacology. (1stedn), W.B. Saunders Company, Philadelphia, London, Toranto.
  2. Zhang Z (2006) Bioinformatics tools for differential analysis of proteomic expression profiling data from clinical samples. Taylor & Francis CRC Press.

Conferences

  1. Hofmann T (1999) The Cluster-Abstraction Model: unsupervised learning of topic hierarchies from text data. Proceedings of the International Joint Conference on Artificial Intelligence.

Tables: These should be used at a minimum and designed as simple as possible. We strongly encourage authors to submit tables as .doc format. Tables are to be typed double-spaced throughout, including headings and footnotes. Each table should be on a separate page, numbered consecutively in Arabic numerals and supplied with a heading and a legend. Tables should be self-explanatory without reference to the text. Preferably, the details of the methods used in the experiments should be described in the legend instead of the text. The same data should not be presented in both table and graph form or repeated in the text. Cells can be copied from an Excel spreadsheet and pasted into a word document, but Excel files should not be embedded as objects.

Note: If the submission is in PDF format, the author is requested to retain the same in .doc format in order to aid in completion of process successfully.

Figures

The preferred file formats for photographic images are .doc, TIFF and JPEG. If you have created images with separate components on different layers, please send us the Photoshop files.All images must be at or above intended display size, with the following image resolutions: Line Art 800 dpi, Combination (Line Art + Halftone) 600 dpi, Halftone 300 dpi. See the Image quality specifications chart for details. Image files also must be cropped as close to the actual image as possible.Use Arabic numerals to designate figures and upper case letters for their parts (Figure 1). Begin each legend with a title and include sufficient description so that the figure is understandable without reading the text of the manuscript. Information given in legends should not be repeated in the text.

Figure legends: These should be typed in numerical order on a separate sheet.

Tables and Equations as Graphics

If equations cannot be encoded in MathML, submit them in TIFF or EPS format as discrete files (i.e., a file containing only the data for one equation). Only when tables cannot be encoded as XML/SGML can they be submitted as graphics. If this method is used, it is critical that the font size in all equations and tables is consistent and legible throughout all submissions. 

Ergänzende Informationen : Alle ergänzenden Informationen (Abbildungen, Tabellen und Übersichtsdiagramme usw.) werden, soweit möglich, als einzelne PDF-Datei bereitgestellt. Dateigröße innerhalb der zulässigen Grenzen für Zusatzinformationen. Bilder sollten eine maximale Größe von 640 x 480 Pixeln (9 x 6,8 Zoll bei 72 Pixel pro Zoll) haben.

Korrekturabzüge und Nachdrucke: Elektronische Korrekturabzüge werden als E-Mail-Anhang als PDF-Datei an den entsprechenden Autor gesendet. Korrekturfahnen gelten als endgültige Fassung des Manuskripts und es werden in der Korrekturphase keine Änderungen am Manuskript vorgenommen. Autoren können die PDF-Datei kostenlos herunterladen. Ausdrucke der Dokumente sind auf Anfrage erhältlich. Bitte klicken Sie auf den Link für die Gebühren. https://www.omicsonline.org/pdfs/OMICS-Group-reprints-order-form.pdf

Urheberrechte ©

Alle von OMICS International veröffentlichten Werke unterliegen den Bedingungen der Creative Commons Attribution License. Dies erlaubt jedem, das Werk zu kopieren, zu verbreiten, zu übertragen und anzupassen, sofern das Originalwerk und die Quelle ordnungsgemäß zitiert werden.

Schneller redaktioneller Ausführungs- und Review-Prozess (FEE-Review-Prozess):

Fortschritte in der Krebsprävention nimmt am Fast Editorial Execution and Review Process (FEE-Review Process) mit einer zusätzlichen Vorauszahlung von 99 US-Dollar zusätzlich zur regulären Artikelbearbeitungsgebühr teil. Der schnelle redaktionelle Ausführungs- und Überprüfungsprozess ist ein spezieller Service für den Artikel, der es ihm ermöglicht, in der Vorprüfungsphase schneller eine Antwort vom behandelnden Redakteur sowie eine Bewertung vom Rezensenten zu erhalten. Ein Autor kann innerhalb von maximal 3 Tagen nach der Einreichung eine schnellere Antwort von der Vorbegutachtung erhalten und innerhalb von maximal 5 Tagen einen Überprüfungsprozess durch den Gutachter, gefolgt von einer Überarbeitung/Veröffentlichung in 2 Tagen. Wenn der Artikel vom zuständigen Redakteur zur Überarbeitung benachrichtigt wird, dauert die externe Begutachtung durch den vorherigen Rezensenten oder alternativen Rezensenten weitere 5 Tage.

Die Annahme von Manuskripten wird ausschließlich durch die Überlegungen des Redaktionsteams und die unabhängige Begutachtung durch Fachkollegen bestimmt, um sicherzustellen, dass die höchsten Standards eingehalten werden, unabhängig vom Weg zu einer regelmäßigen Veröffentlichung durch Fachkollegen oder einem schnellen redaktionellen Begutachtungsprozess. Für die Einhaltung wissenschaftlicher Standards sind der behandelnde Herausgeber und der Artikelautor verantwortlich. Die Gebühr für die Überprüfung des Artikels in Höhe von 99 US-Dollar wird nicht erstattet, selbst wenn der Artikel abgelehnt oder zur Veröffentlichung zurückgezogen wird.

Der entsprechende Autor bzw. die entsprechende Institution/Organisation ist für die Zahlung der Manuskriptgebühr für den Begutachtungsprozess verantwortlich. Die zusätzliche Zahlung für den FEE-Review-Prozess deckt die schnelle Verarbeitung von Rezensionen und schnelle redaktionelle Entscheidungen ab. Die regelmäßige Veröffentlichung von Artikeln deckt die Vorbereitung in verschiedenen Formaten für die Online-Veröffentlichung ab und sichert die Aufnahme des Volltextes in eine Reihe permanenter Archive wie HTML, XML und PDF. und Weitergabe an verschiedene Indexierungsagenturen.